
Louis Allott, PhD
Director
Louis is a radiochemist with fifteen years across academia, industry and the NHS. He designs radiolabelling routes, takes them through process development and automation, and transfers them into GMP production. He has established and operated radiopharmaceutical facilities in the UK for both research and clinical manufacture, and has taken tracers from first synthesis through to use in patients. He founded Radiopharmium in December 2024 and holds fractional director-level roles with the Daisy Appeal and Aptamer Group.


